These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 7668140)
1. Marijuana, receptors and immunomodulation. Friedman H; Klein TW; Newton C; Daaka Y Adv Exp Med Biol; 1995; 373():103-13. PubMed ID: 7668140 [TBL] [Abstract][Full Text] [Related]
2. Psychoactive cannabinoids increase mortality and alter acute phase cytokine responses in mice sublethally infected with Legionella pneumophila. Smith MS; Yamamoto Y; Newton C; Friedman H; Klein T Proc Soc Exp Biol Med; 1997 Jan; 214(1):69-75. PubMed ID: 9012363 [TBL] [Abstract][Full Text] [Related]
3. delta 9-Tetrahydrocannabinol, cytokines, and immunity to Legionella pneumophila. Klein TW; Newton C; Zhu W; Daaka Y; Friedman H Proc Soc Exp Biol Med; 1995 Jul; 209(3):205-12. PubMed ID: 7777582 [TBL] [Abstract][Full Text] [Related]
4. Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection. Klein TW; Newton CA; Nakachi N; Friedman H J Immunol; 2000 Jun; 164(12):6461-6. PubMed ID: 10843702 [TBL] [Abstract][Full Text] [Related]
5. Relationship of aging and cytokines to the immunomodulation by delta-9-tetrahydrocannabinol on murine lymphoid cells. Snella E; Pross S; Friedman H Int J Immunopharmacol; 1995 Dec; 17(12):1045-54. PubMed ID: 8964654 [TBL] [Abstract][Full Text] [Related]
6. The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2. Newton CA; Lu T; Nazian SJ; Perkins I; Friedman H; Klein TW J Leukoc Biol; 2004 Oct; 76(4):854-61. PubMed ID: 15258190 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptors and the cytokine network. Klein TW; Newton C; Friedman H Adv Exp Med Biol; 1998; 437():215-22. PubMed ID: 9666274 [TBL] [Abstract][Full Text] [Related]
8. Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Roth MD; Baldwin GC; Tashkin DP Chem Phys Lipids; 2002 Dec; 121(1-2):229-39. PubMed ID: 12505703 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo suppressive effects of delta-9-tetrahydrocannabinol on interferon production by murine spleen cells. Blanchard DK; Newton C; Klein TW; Stewart WE; Friedman H Int J Immunopharmacol; 1986; 8(7):819-24. PubMed ID: 2430904 [TBL] [Abstract][Full Text] [Related]
10. Age-related suppression of murine lymphoid cell blastogenesis by marijuana components. Pross SH; Klein TW; Newton C; Smith J; Widen R; Friedman H Dev Comp Immunol; 1990; 14(1):131-7. PubMed ID: 2159920 [TBL] [Abstract][Full Text] [Related]
11. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Oviedo A; Glowa J; Herkenham M Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305 [TBL] [Abstract][Full Text] [Related]
12. Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction. Chang X; Bian Y; He Q; Yao J; Zhu J; Wu J; Wang K; Duan T Cell Physiol Biochem; 2017; 42(2):537-550. PubMed ID: 28578322 [TBL] [Abstract][Full Text] [Related]
13. Drugs of abuse and virus susceptibility. Friedman H; Klein T; Specter S; Pross S; Newton C; Blanchard DK; Widen R Adv Biochem Psychopharmacol; 1988; 44():125-37. PubMed ID: 2840802 [TBL] [Abstract][Full Text] [Related]
14. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. Zhu LX; Sharma S; Stolina M; Gardner B; Roth MD; Tashkin DP; Dubinett SM J Immunol; 2000 Jul; 165(1):373-80. PubMed ID: 10861074 [TBL] [Abstract][Full Text] [Related]
15. The role of macrophages in THC-induced alteration of the cytokine network. Newton C; Klein T; Friedman H Adv Exp Med Biol; 1998; 437():207-14. PubMed ID: 9666273 [TBL] [Abstract][Full Text] [Related]
16. Differing effects of delta-9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulators. Pross SH; Nakano Y; Widen R; McHugh S; Newton CA; Klein TW; Friedman H Int J Immunopharmacol; 1992 Aug; 14(6):1019-27. PubMed ID: 1330945 [TBL] [Abstract][Full Text] [Related]
17. Age related immunomodulation in murine splenocytes induced by delta-9-tetrahydrocannabinol (THC). Pross S; Nakano Y; Widen R; McHugh S; Friedman H Mech Ageing Dev; 1993 May; 68(1-3):11-26. PubMed ID: 8394485 [TBL] [Abstract][Full Text] [Related]
18. Differential immunologic modulatory effects of tetrahydrocannabinol as a function of age. Ramarathinam L; Pross S; Plescia O; Newton C; Widen R; Friedman H Mech Ageing Dev; 1997 Jun; 96(1-3):117-26. PubMed ID: 9223115 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of cannabinoids. Grotenhermen F Clin Pharmacokinet; 2003; 42(4):327-60. PubMed ID: 12648025 [TBL] [Abstract][Full Text] [Related]
20. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. Do Y; McKallip RJ; Nagarkatti M; Nagarkatti PS J Immunol; 2004 Aug; 173(4):2373-82. PubMed ID: 15294950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]